The outbreak of COVID-19 started in December 2019 and spread rapidly all over the world.
It became clear that the development of an effective vaccine was the only way to stop the …

Background Understanding the incidence pattern of cutaneous reactions is crucial for
promoting COVID-19 vaccination. We aimed to report the global incidence pattern of, and …

Background Efficacy and safety are fundamental for the development of successful COVID-
19 vaccines. Vaccine-associated side effects influence vaccine hesitancy. This study …

Introduction Starting in December 2021, the Indonesian Government has recommended
inactivated SARS-CoV-2 vaccine (CoronaVac) for children aged 6–11 years. This study …

Indian data regarding serious neurological and psychiatric adverse events, following
coronavirus disease 2019 (COVID-19) vaccination, are lacking. We, therefore, systematically …

Background The safety of the COVID-19 vaccines has been a topic of concern globally. This
issue of safety is associated with vaccine hesitancy due to concerns about the adverse …

Objective: This study sought to assess the prevalence of adverse events following
immunization (AEFI) and factors associated with AEFI of the ChAdOx1 nCoV-19 vaccine …

Zusammenfassung Einleitung Im Rahmen einer akuten COVID-19-Infektion (Coronavirus
SARS-CoV‑2 Infektion) treten in 10–60% der Patient: innen Kopfschmerzen auf, die Tage …

Background: COVID vaccination is now offering a way to transit out of this phase of the
pandemic. Two vaccines were approved by the Central Drugs Standard Control …

Background Huge efforts have been made for vaccine research and administration in light of
the public health measures implemented for the COVID-19 pandemic. Safety information …